Aegeline attenuates TNBS-induced colitis by suppressing the NFƙB-mediated NLRP3 inflammasome pathway in mice
- PMID: 38767762
- DOI: 10.1007/s10787-024-01493-0
Aegeline attenuates TNBS-induced colitis by suppressing the NFƙB-mediated NLRP3 inflammasome pathway in mice
Abstract
A chronic inflammatory condition of the intestine, ulcerative colitis (UC), is challenging to successfully manage once diagnosed. Currently, available medical therapies for UC exhibit minimal efficacy with unacceptable side effects, while inventive biological agents are expensive and yet not well accepted by patients. Discovering more effective and safer treatments to treat UC is therefore essential. One of the primary alkaloids found in Aegle marmelos, aegeline, has anti-inflammatory and antioxidant properties as well as being able to suppress several pro-inflammatory cytokines responsible for inflammation. The study aimed to investigate the effectiveness of aegeline in alleviating 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis through the NFƙB-mediated NLRP3 inflammasome pathway. Mice were randomly allocated into six groups, Normal control (NC), Model control (MC-TNBS, 2,4,6-trinitrobenzene sulfonic acid), STD (TNBS + sulfasalazine 100 mg/kg), AG1, AG2, and AG3 (TNBS + aegeline 5, 10, 20 mg/kg) respectively. Physical parameters such as a change in body weight, stool consistency, rectal bleeding, colon length, myeloperoxidase (MPO) levels and nitric oxide (NO) levels, and disease activity index (DAI) were assessed and supporting gene expression studies of various pro-inflammatory cytokines and enzymes were evaluated and histopathological changes observed. Administration of aegeline (10, 20 mg/kg) was found to be effective in colon protection by lowering the disease activity score and myeloperoxidase level and improving other physical parameters. Aegeline in high dose significantly downregulated the gene expression of NFƙB, iNOS, COX-2, NLRP3, IL-1β, and IL-18, conferring great anti-inflammatory potential. Suggestive of the findings, aegeline reduced the damage to the colon by downregulating transcriptional genes and enzymes leading to inflammation and mitigated TNBS-induced colitis probably through the NFƙB-mediated NLRP3 inflammasome pathway.
Keywords: Aegeline; Inflammatory bowel disease; NFƙB pathway; NLRP3 inflammasome; Ulcerative colitis.
© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
References
-
- Alves De Almeida AC, De-Faria FM, Dunder RJ, et al (2017) Recent trends in pharmacological activity of alkaloids in animal colitis: potential use for inflammatory bowel disease. Evid Based Complement Altern Med: 1–24
-
- Bergmann MM, Hernandez V, Bernigau W et al (2017) No association of alcohol use and the risk of ulcerative colitis or Crohn’s disease: data from a European prospective cohort study (EPIC). Eur J Clin Nutr 71:512–518. https://doi.org/10.1038/EJCN.2016.271 - DOI - PubMed
-
- Bin LS, Lee WS, Shin JS et al (2017) Xanthotoxin suppresses LPS-induced expression of iNOS, COX-2, TNF-α, and IL-6 via AP-1, NF-κB, and JAK-STAT inactivation in RAW 264.7 macrophages. Int Immunopharmacol 49:21–29. https://doi.org/10.1016/j.intimp.2017.05.021 - DOI
-
- Boaru SG, Borkham-Kamphorst E, Van De Leur E et al (2015) NLRP3 inflammasome expression is driven by NF-κB in cultured hepatocytes. Biochem Biophys Res Commun 458:700–706. https://doi.org/10.1016/J.BBRC.2015.02.029 - DOI - PubMed
-
- Bunsupa S, Yamazaki M, Saito K (2012) Quinolizidine alkaloid biosynthesis: recent advances and future prospects. Front Plant Sci. https://doi.org/10.3389/fpls.2012.00239 - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Research Materials
Miscellaneous